Natural Alternatives International (NAII)
Natural Alternatives International Revenues: 16.16M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
NAII Revenues Rankings
| Overall | 19th percentile | 3581 of 4432 |
| Sector | 41st percentile | 273 of 470 in Healthcare |
| Industry | 9th percentile | 9 of 10 in Drug Related Products |
NAII Revenues Range, Past 5 Years
| Minimum | 13.36M | Sep 2010 |
| Maximum | 25.52M | Sep 2007 |
| Average | 18.07M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these NAII related companies
NAII News
Natural Alternatives Internati (NAII) Reports Q3 Earnings of $0.15/Share
May 14, 4:38PM Street Insider
May 14, 4:38PM Street Insider
Natural Alternatives International, Inc. Announces Fiscal 2012 Q3 and YTD Results
May 14, 4:30PM PR Newswire
May 14, 4:30PM PR Newswire
Natural Alternatives International (NAII) Files Patent Infringement Suit Against DNP International
Feb 14, 4:06PM Street Insider
Feb 14, 4:06PM Street Insider
Natural Alternatives International Files Patent Infringement Claim Against DNP International Co
Feb 14, 4:01PM Benzinga
Feb 14, 4:01PM Benzinga
Natural Alternatives International, Inc. Files Patent Infringement Claim Against DNP International Co., Inc.
Feb 14, 4:00PM PR Newswire
Feb 14, 4:00PM PR Newswire
Natural Alternatives Internati (NAII) Reports Q2 Earnings of $0.11, Sales Grow Y/Y
Feb 13, 4:50PM Street Insider
Feb 13, 4:50PM Street Insider
Natural Alternatives International, Inc. Announces Fiscal 2012 Q2 Results
Feb 13, 4:47PM PR Newswire
Feb 13, 4:47PM PR Newswire
Natural Alternatives International Announces Texas Suit Against Woodbolt Distribution
Dec 22, 9:17AM Benzinga
Dec 22, 9:17AM Benzinga
Natural Alternatives International, Inc. Announces Fiscal 2012 Q1 Results
Nov 14, 9:15AM PR Newswire
Nov 14, 9:15AM PR Newswire
$NAII filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/gm0
about 225 days ago by MarketBrief
about 225 days ago by MarketBrief
Natural Alternatives International renews beta-alanine licensing agreement
Aug 12, 8:36AM FlyOnTheWall
Aug 12, 8:36AM FlyOnTheWall
Natural Alternatives International announces resolution of patent litigation
Aug 12, 8:34AM FlyOnTheWall
Aug 12, 8:34AM FlyOnTheWall
$NAII $3.88 LEDOUX MARK A CEO P 3,000 @ $3.59 amnt $10,770 proc'd $870 6/16/2011
about 345 days ago by canarionyc
about 345 days ago by canarionyc
$NAII $3.58 WOLF KENNETH CFO P 10,100 @ $3.27 amnt $32,979 proc'd $3,177 6/6/2011
about 357 days ago by canarionyc
about 357 days ago by canarionyc
$NAII obvious BUY now. No other stock out there can be a greater buy than $NAII in my opinion. For April6, this the one right here right now
about 421 days ago by ninanina65
about 421 days ago by ninanina65
San Marcos' Natural Alternatives sues 2 companies for patent infringement, unfair competition http://bit.ly/1WrOyq $NAII +$0.06
about 932 days ago by SDDTfinance
about 932 days ago by SDDTfinance
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NAII | 7.500 | -0.00 | -0.00% | 52.28M |
| NAI | 10.03 | -0.13 | -1.28% | |
| NAGS | 10.69 | -0.47 | -4.21% | |
| NAFC | 20.42 | +0.09 | +0.44% | 248.23M |
| NAD | 14.93 | -0.02 | -0.13% | |
| NABI | 1.60 | +0.00 | +0.00% | 68.62M |
| N | 46.64 | -0.30 | -0.64% | 3.260B |
| MZZ | 32.80 | +1.23 | +3.90% | |
| MYY | 28.65 | +0.54 | +1.94% | |
| MYRX | 2.45 | -0.07 | -2.78% | 66.48M |
